Cigna Group — Director's Dealing 2021

May 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-05-04

Reporting Person: Cordani David (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-04	Common Stock, $.01 Par Value	M	42772.0000	$78.0350	Acquired	140253.0000	Direct
2021-05-04	Common Stock, $.01 Par Value	S	379.0000	$259.1934	Disposed	139874.0000	Direct
2021-05-04	Common Stock, $.01 Par Value	S	1367.0000	$256.4266	Disposed	138507.0000	Direct
2021-05-04	Common Stock, $.01 Par Value	S	3325.0000	$258.4242	Disposed	135182.0000	Direct
2021-05-04	Common Stock, $.01 Par Value	S	5510.0000	$257.5190	Disposed	129672.0000	Direct
2021-05-04	Common Stock, $.01 Par Value	S	32191.0000	$255.1274	Disposed	97481.0000	Direct
2021-05-05	Common Stock, $.01 Par Value	M	14237.0000	$78.0350	Acquired	111718.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-04	Employee Stock Option (Right to Buy)	$78.0350	M	42772.0000	Disposed	2024-02-26	Common Stock, $.01 Par Value (42772.0000)	Direct
2021-05-05	Employee Stock Option (Right to Buy)	$78.0350	M	14237.0000	Disposed	2024-02-26	Common Stock, $.01 Par Value (14237.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.01 Par Value	1647.1673	Indirect
Common Stock, $.01 Par Value	424611.0000	Indirect

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.

F2: Represents the weighted average price of the shares sold. The prices actually received ranged from $259.015 to $259.39 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F3: Represents the weighted average price of the shares sold. The prices actually received ranged from $256.00 to $256.975 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F4: Represents the weighted average price of the shares sold. The prices actually received ranged from $258.00 to $258.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F5: Represents the weighted average price of the shares sold. The prices actually received ranged from $257.00 to $257.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F6: Represents the weighted average price of the shares sold. The prices actually received ranged from $255.00 to $255.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F7: Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.

F8: This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.